Ironwood Pharmaceuticals Inc IRWD released topline results from its pivotal Phase 3 STARS trial of once-weekly subcutaneous apraglutide in reducing parenteral...
NASDAQIRWD
Exclusive
Breaking News
Research on college students’ mental health education: the mediating role and the moderating effect of resource allocation
Mental Health Problems Among Medical Students | The psychological anatomy of becoming a doctor
Do No Harm: Rethinking Diabetes, Hypertension in Frail Older Adults
Give Kids A Smile 2026 kicks off in Houston